I'm happy to come back in a month or so to review.

Quote:

---

I'm happy to come back in a month or so to review.

---

Make it six months.

You're still posting theory as fact. We don't know what's going on. The company only broke their self-imposed silence because of the clinical holds. We still don't know if they initially went silent because there are developments they cannot share with us, they no longer care about shareholders, or they had nothing to say.

Considering the 700ml NASH data seems to be something they are purposely holding back, that suggests there *are* developments that have yet to be made public. You don't tell shareholders "partnerships are looking very strong" and "NASH results coming soon," then go dark for 3 months purely for shits and giggles.

See you in October.